Glaxo sets aside $3.4 billion to cover costs over Avandia

The drug maker GlaxoSmithKline PLC has indicated that it will set aside $3.4 billion to cover costs associated with Avandia lawsuits and a federal investigation into their actions surrounding the disclosure of potential side effects of Avandia, which has been linked to an increased risk of heart attacks and heart failure. Go here for the full story.